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We sought in this study to clarify the role that familial factors play in 
influencing the clinical presentation of major depression (MD). We examined 
the similarity of the historical and symptomatic features of MD in 176 
pairs of female-female monozygotic (MZ) and dizygotic (DZ) twins from a 
population-based registry, where both members reported a history of MD 
defined by DSM-111-R criteria. The age at onset and treatment-seeking were 
significantly correlated in all twin pairs and the correlation in concordant 
DZ pairs was actually somewhat higher than in concordant MZ twins. The 
degree of impairment was modestly correlated in all twin pairs with 
substantially higher correlations in MZ vs DZ twins. No twin resemblance 
was observed for number of episodes or longest duration of an episode. 
Twin resemblance for the clinical features of MD was modest, but so was 
their consistency for the same individual over successive 1-year periods. 
However, in 5 of the 6 neurovegetative symptoms involving changes in 
appetite, weight and sleep, MZ twins were significantly correlated and 
correlations were significantly greater in concordant MZ vs DZ twins. 
Although the familial factors that cause twin resemblance for the age at onset 
and treatment seeking appear to be largely environmental, twin 
resemblance for the degree of impairment and neurovegetative symptoms 
are probably due largely to genetic factors. Our results suggest that familial 
factors influence the predisposition to some clinical features of MD. 
Major depression (MD) has consistently been shown 
to aggregate (or run) in families (1). Studies have 
also examined whether certain clinical characteris- 
tics of M D  predict the risk of illness in relatives, 
including age at onset (2-4), recurrence (5, 6), se- 
verity of impairment (5), number or kind of depres- 
sive symptoms (7,8) and comorbidity (2,9). Much 
less frequently examined has been the degree to 
which speclfic historical and clinical characteristics 
of M D  are themselves familial (10-13). That is, when 
pairs of relatives are both affected with MD, how 
similar are the clinical features of their disorders? 
The answer to such a question is of interest be- 
cause it may clarify the nature of the familial influ- 
ences on MD. For example, the familial influences 
on MD may be nonspecific in that they influence 
overall risk for MD but play no role in shaping the 
features of MD once an individual becomes affected. 
This hypothesis predicts that the clinical features of 
pairs of relatives both affected with MD will be un- 
correlated. By contrast, the familial factors for M D  
could be specific in that they influence both the over- 
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all liability to illness and the clinical features of the 
disorder in affected individuals. If true, this would 
predict considerable resemblance in pairs of affected 
relatives for the specific clinical features of MD. 
We examined this question in 176 pairs of female- 
female twins from a population-based twin register 
in which both members reported, at some point in 
their lives, one or more episodes of M D  meeting 
DSM-111-R criteria (14). Although limited by small 
sample size, a comparison of the correlations in con- 
cordant MZ vs DZ twins can begin to provide some 
insight into whether an observed familial resem- 
blance for the clinical features of MD is the result of 
familial-environmental or genetic factors. 
Material and methods 
The data for this report come from a study of genetic 
and environmental risk factors for common mental 
disorders in Caucasian female same-sex twin pairs 
from the Virginia Twin Registry (15). The study was 
restricted to women, who were chosen because they 
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would, compared to men, have substantially higher 
prevalence rates for mood and anxiety disorders. 
The Virginia Twin Registry is a population-based 
register formed from a systematic review of all birth 
certificates, from 1918 onwards, in the Common- 
wealth of Virginia. The current addresses are ob- 
tained largely by matching to state records. 
Twins were eligible to participate in this study if 
they were born between 1934 and 1971 and both 
members of the pair had previously responded to a 
mailed questionnaire, to which the individual re- 
sponse rate was approximately 64%. The coopera- 
tion rate was almost certainly higher than this, as an 
unknown number of twins did not receive their ques- 
tionnaire due to faulty addresses, improper forward- 
ing of mail, etc. Of the total 1176 eligible pairs, nei- 
ther twin was successfully interviewed in 46, one 
twin was interviewed and the other refused in 97 and 
interviews were completed with both members of 
1033 twin pairs. The individual cooperation rate was 
92%. Of the completed interviews, 89% were com- 
pleted face to face, nearly all in the twin’s home, and 
11 % (mostly twins living outside Virginia) were in- 
terviewed by telephone. The mean age ( & SD) of the 
sample at first interview was 30.1 & 7.6 and ranged 
from 17 to 55 .  Zygosity was determined blindly by 
standard questions (16), photographs, and when 
necessary, DNA (17). 
Attempts were made to recontact all 2163 origi- 
nally interviewed twins a minimum of 1 year after 
their first assessment. We completed a second in- 
terview in 2001 (93%) of them. Unlike the first in- 
terview, nearly all of the second ones (99%) were 
completed by phone. Both interviews were con- 
ducted by trained social workers, blind to the status 
of the co-twin. 
The first interview contained an adapted version 
of the Structured Interview for DSM-111-R (18) to 
assess the lifetime history of MD up to 1 year prior 
to the interview. In addition, both interviews inquired 
of all respondents whether, in the last year, they had 
experienced 20 specific mental symptoms, including 
all of the DSM-111-R criteria for MD (14). In each 
of these assessments, we disaggregated the 9 indi- 
vidual symptomatic criteria for MD in DSM-111-R, 
assessing separately weight loss, decreased appetite, 
weight gain, increased appetite, insomnia, hypersom- 
nia, psychomotor agitation and psychomotor retar- 
dation. Together with depressed mood, loss of in- 
terest or pleasure, fatigue or tiredness, feelings of 
worthlessness or guilt, trouble thinking or concen- 
trating and suicidal ideation, this meant that we as- 
sessed 14 individual depressive symptoms. How- 
ever, as nearly all depressed individuals endorsed 
depressed mood, this item was insufficiently variable 
to be usefully analyzed. In addition to symptoms, 
individuals who met 3 or more symptomatic criteria 
were asked an additional series of questions that 
included: age at first episode, total number of epi- 
sodes, duration of longest episode, degree of impair- 
ment during worst episode (scored as severe impair- 
ment or incapacitation, moderate impairment and 
no impairment) and treatment-seeking. Treatment- 
seeking was assessed by the question “During any 
of these times, did you seek professional help for the 
way you were feeling?”. Because of their expected 
rarity in a general population sample, psychotic 
symptoms during the depressive episode were not 
assessed. 
Interrater reliability for the first interview was as- 
sessed in 53 jointly conducted interviews. For the 
DSM-111-R diagnosis of MD, reliability was very 
high (~=0 .96&0.04) .  In the 18 cases where both 
raters agreed on the presence of MD, the individual 
symptoms were rated as present or absent with high 
reliability (K = 0.98 5 0.02). 
DSM-111-R criteria for MD were assessed by 
computer algorithm. MD was not diagnosed when 
somatic illness or drugs were likely causes of the 
depressive syndrome or when the depressive syn- 
drome represented normal grief. 
Each twin was assessed for MD for 3 time peri- 
ods: lifetime prior to l year before the first interview, 
1 year prior to the first interview and 1 year prior to 
the second interview. Age at onset was defined as the 
youngest age at which she reported an episode at any 
assessment. Longest duration was defined as the 
longest duration reported at any assessment. Im- 
pairment was defined as the most severe impairment 
reported at any assessment. The number of episodes 
was the total reported episodes summed over all 3 
assessments. We also analyzed this variable as a 
dichotomy, termed recurrence, separating twins with 
only 1 lifetime episode of illness versus those with 
more than one. Treatment-seeking was scored 
present if it was reported at any assessment. The 
number of DSM-111-R criteria was chosen from the 
interview with the highest number of endorsed cri- 
teria. For individual symptoms in individuals with 
more than one episode, we used 2 rules for choos- 
ing which episode to examine: the one with the most 
symptoms or the one with the greatest impairment. 
In each case, ties were broken by taking the more 
recent episode. The overall results were quite simi- 
lar for the 2 methods and we here report results from 
the episode with the most symptoms. 
In this article, we use the term clinical features to 
refer to the following variables: age at onset, dura- 
tion of the longest episode, impairment during worst 
episode, total number of episodes, recurrence, 
treatment-seeking and number of DSM-111-R crite- 
ria met during worst episode. We use the term symp- 
toms to refer to the 13 disaggregated DSM-111-R 
criteria. 
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Twin correlations for any variable are perforce 
limited by the reliability of that variable. To assess 
this reliability, we compared the available clinical 
features of MD for the 54 twins who met criteria 
both for the year prior to the first and the year prior 
to the second interview. These individuals were as- 
sessed using the identical interview format at a mean 
interval of 17 months. This analysis jointly assesses 
both the reliability of experiencing the clinical fea- 
tures of depression over separate episodes and the 
reliability of reporting them. It therefore differs from 
the other previous examination of this issue (19), 
which examines only the latter. 
Statistical analysis 
For continuous measures, we calculated the product- 
moment correlations. We also repeated these after 
transformation to reduce skewness and found only 
insignificant changes. For dichotomous or polychot- 
omous variables, we calculated tetrachoric and poly- 
choric correlations, respectively, using the program 
PRELIS I1 (20). As we a priori expect only positive 
correlations, we present one-tailed P values. The dif- 
ferences between the observed correlations in MZ 
and DZ twins were tested by a chi-square difference 
test with one degree of freedom using the program 
LISREL (21) in which we allowed the two correla- 
tions to differ and then constrained them to equal- 
ity. In comparing the MZ and DZ correlations, we 
used a one-tailed test and do not report significance 
if the results ran counter to expectation (correlations 
higher in DZ twins). We consider these analyses 
exploratory and therefore make no attempt at cor- 
rection for multiple tests. 
Results 
Total sample of concordant pairs 
We began by examining the 176 twin pairs where 
both members reported one or more lifetime epi- 
sodes of MD (Table 1, first column). In these pairs, 
age at onset ( r  = 0.34) and treatment seeking(r = 0.25) 
were correlated (P<O.OOl for both). Degree of im- 
pairment ( r  = 0.14) and number of symptoms 
( r  = 0.14) were also correlated but at a substantially 
lower level (P< 0.05). Duration of longest episode 
and number of episodes, measured as a continuous 
variable or dichotomized into those with recurrent vs 
nonrecurrent illness, were effectively uncorrelated in 
pairs of affected twins. 
Of the 13 symptoms of M D  examined, twin pairs 
concordant for one or more lifetime episodes of MD 
were significantly correlated for 5 of them: loss of 
interest or pleasure ( r  = 0.22), weight gain (r  = 0.28), 
increased appetite ( r  = 0.33), psychomotor retarda- 
tion ( r  = 0.18) and suicidal ideation (r  = 0.25). Sim- 
Table 1. Similarity in concordant twin pairs and test-retest reliability for the clinical 
features and symptoms of major depression 
All MZ 02 
twin pairs twin pairs twin pairs Test- 
concordant concordant concordant retest 
for MD for MD for MD MZ-DZ reliablity 
Variable n=176 n=103 n=73 difference n=54 
Clinical features 
Age at onset 
Longest duration 
Impairment 
Number of episodes 
Recurrence 
Treatment-seeking 
Number of symptoms 
Symptoms 


































































































-Against one-tailed prediction, no P value reported. P values (one-tailed): *P<O. 10; ’ PC0.05; ’ P<O.Ol; ’ P<O.OOl. N Not assessed or not assessable due to too 
little variance. 
ilarity in these twin pairs for weight loss ( r =  0.12) 
and difficulty concentrating ( r  = 0.10) were present 
at the trend level only. 
Concordant MZ and DZ twin pairs 
The sample contained 103 MZ and 73 DZ twin pairs 
concordant for the presence of one or more episodes 
of MD by DSM-111-R criteria. Concordant MZ twin 
pairs were significantly correlated for 5 of the 7 clin- 
ical features of MD: age at onset ( r =  0.20), impair- 
ment ( r  = 0.25), recurrence ( r  = 0.26), treatment- 
seeking ( r  = 0.18) and total number of symptoms 
( r  = 0.14). Although significantly correlated for re- 
currence, MZ twins were entirely uncorrelated for 
the total number of lifetime episodes. DZ twin pairs 
were significantly correlated for 3 clinical features of 
MD: age at onset ( r  = 0.48), number of episodes 
( r  = 0.22) and treatment-seeking ( r  = 0.34). The cor- 
relation in concordant MZ twin pairs significantly 
exceeded that found in DZ pairs only for recurrence 
and, at a trend level, for degree of impairment. 
Concordant MZ twin pairs were significantly and 
positively correlated for 7 of the 13 individual symp- 
toms, compared with 3 in the concordant DZ twin 
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pairs. Five of the 7 significant correlations in MZ 
twin pairs were from vegetative symptoms reflecting 
depression-related changes in appetite, weight and 
sleep. In 7 symptoms (weight loss, decreased appe- 
tite, weight gain, insomnia, hypersomnia, trouble 
concentrating and suicidal ideation), of which 5 were 
vegetative, the correlations in concordant MZ twin 
pairs significantly exceeded those found in D Z  twin 
pairs. 
Reliability of clinical features and symptoms 
Twin correlations for a variable are, per force, lim- 
ited by the degree of measurement error. In general, 
twins should not correlate more highly with one an- 
other than individuals would correlate with them- 
selves over time. Our sample contained 54 individ- 
uals who reported one or more episodes of M D  in 
the last year both at our first and second interviews. 
The correlations between the reported clinical fea- 
tures of these episodes are seen in the last column 
of Table 1. Three of the 6 assessed clinical variables 
(longest duration, number of episodes in the last year 
and impairment) were significantly correlated over 
time whereas, somewhat surprisingly, treatment- 
seeking and total number of symptoms were not. Of 
the 12 assessed symptoms, twins significantly cor- 
related with themselves over time in 7 of them, of 
which4 werevegetative symptoms. Themean ( & SD) 
correlation of all 12 symptoms in concordant MZ 
twins (Y = 0.18 & 0.16) is about two-thirds as large as 
the mean correlation of individuals with themselves 
over time (Y = 0.28 0.26). 
Discussion 
We sought to understand in this study the degree to 
which familial factors influence the clinical features 
and symptoms of MD. We know that M D  runs in 
families, but we know little about whether an indi- 
vidual’s family background influences the clinical 
characteristics of M D  they display if they become 
affected. 
We found that age at onset of MD was signifi- 
cantly correlated in all twin pairs where both mem- 
bers had one or more lifetime episodes of MD. The 
magnitude of this correlation (Y = 0.34) is within the 
range previously reported in pairs of first degree rel- 
atives by Slater (10) (Y= 0.35), Gershon et al. (12) 
(Y = 0.40) and Maier (1 1) (Y = 0.20). Winokur (22) 
has also reported a significant association between 
age at onset, dichotomized into early and late, in 
depressive subjects and their affected relatives. Con- 
trary to expectation, age at onset was more similar 
in concordant DZ than in concordant MZ twins. 
This pattern of findings suggests that the similarity 
of age at onset of M D  in pairs of relatives is prob- 
ably due to familial-environmental and not genetic 
factors. 
Although the correlation in age at onset of M D  in 
relatives was relatively modest, these results must be 
interpreted in the context of the reliability of this 
variable. Bromet et al. (19) found the test-retest re- 
liability of age at first episode to be Y =  0.51 in a 
community sample. If generalizable, this would sug- 
gest that 60% or more of the reliable variance in age 
at onset of M D  may be due to familial factors. 
The degree of impairment during the worst epi- 
sode of M D  was modestly correlated in all concor- 
dant twin pairs and, at a trend level, more signifi- 
cantly correlated in MZ than in DZ twins. This 
feature was also one of the most stable across time 
within the same individual. The correlation in the 
degree of impairment in concordant MZ twins was 
about 40% as large as that from the same individ- 
ual measured twice. We know of no previous report 
that has examined resemblance in relatives for this 
clinical feature of MD. In this sample (23) and in the 
one previous study to examine this question (6), de- 
gree of impairment was a strong predictor of the risk 
of M D  in co-twins. These results, taken together, 
tentatively suggest that the degree of impairment may 
be an index of the genetic liability to MD. 
The total numbers of lifetime episodes were not 
significantly correlated in all or in MZ twin pairs. 
However, treated as a dichotomy of recurrence- 
nonrecurrence, concordant MZ twin pairs were sig- 
nificantly correlated, and their correlation signifi- 
cantly exceeded that found in D Z  twins. These 
results are consistent with those of Maier et al. (1 l), 
who found that the risk for recurrent depression was 
substantially higher in relatives of subjects with re- 
current vs nonrecurrent MD. Our findings are less 
compatible with those from Slater’s twin-family 
study in which he found no substantial resemblance 
for recurrence rates in affected relatives (10). Our 
results are consistent with the hypothesis that, given 
depressive illness, genetic factors may influence 
whether a recurrent or nonrecurrent variety occurs. 
However, given the recurrent form, the actual num- 
ber of episodes experienced may be influenced largely 
by environmental experiences not shared in twin 
pairs. 
Treatment-seeking was highly significantly corre- 
lated in concordant twin pairs. The correlations for 
help-seeking were actually higher in DZ than in MZ 
twins. Consistent with previous literature, these re- 
sults suggest that whether an individual seeks pro- 
fessional help, given a state of depression, is influ- 
enced by family background and not genetic factors. 
Although we are unaware of previous studies that 
have explicitly addressed this question, 2 studies 
have reported results that are broadly relevant. In 
McGuffin’s recently published twin study of MD, 
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the diagnosis of MD required treatment-seeking (24). 
Although the estimated heritability of liability to MD 
( 5  1 %) was similar to the 2 other comparable twin 
studies (15, 25), the estimated proportion of liability 
due to familial environment (3 1 %) was much higher. 
When McGuffin completed a blind diagnosis of this 
same sample when treatment was no longer a diag- 
nostic criteria for MD, the estimated proportion of 
variance due to the family environment dropped to 
zero (P. McGuffin, personal communication, 11/91). 
He suggested that the probability of help-seeking 
given MD might be influenced by familial environ- 
mental factors. A similar conclusion was reached 
from the Stockholm adoption study, in which diag- 
noses were based on sick leave and medical records 
(26). Here, the investigators found a significant re- 
lationship between the risk of mental illness in 
adopted children and their adoptive parents, but it 
was not specific to any diagnosis. They suggested 
that this pattern may result from the non-genetic 
parent offspring transmission of help-seeking behav- 
ior. 
The longest duration of an episode of MD was not 
significantly correlated in concordant twin pairs. 
Slater also found no significant resemblance for the 
duration of affective illness in pairs of affected rel- 
atives from his twin-family study (10). 
Overall, the resemblance of pairs of affected twins 
for individual depressive symptoms was quite mod- 
est. All concordant pairs were positively correlated 
for only 5 of 13 examined, symptoms with an aver- 
age correlation across all symptoms of only r = 0.1 1. 
Despite these unimpressive correlations, 2 trends 
are noteworthy. First, in all twin pairs, but especially 
in concordant MZ twin pairs, much of the twin sim- 
ilarity was concentrated in symptoms that reflected 
the vegetative features of MD. Five of the 6 symp- 
toms reflecting depression-related changes in weight, 
appetite and sleep were significantly correlated in 
MZ twin pairs concordant for MD. Furthermore, 
for all 6 vegetative symptoms, concordant MZ twins 
resembled one another substantially more than con- 
cordant DZ twins, and this difference was signifi- 
cant for 5 of them. 
This pattern of results would be expected if both 
classic MD, with the tendency toward decreased 
appetite, weight loss and insomnia, and atypical M D  
(27-29), which frequently presents with reverse veg- 
etative features of increased appetite, weight gain 
and hypersomnia, were each influenced by genetic 
factors, but the genetic factors for the 2 conditions 
were at least partly independent. 
We are unaware of any previous results that ad- 
dress the similarity of vegetative features in pairs of 
relatives affected with MD. Of some relevance, how- 
ever, is the finding of Leckman et al. (13) that the 
risk for endogenous MD is substantially higher in 
relatives of subjects with endogenous vs non- 
endogenous MD. Three of the 10 symptomatic cri- 
teria for endogenous MD in their study involved 
insomnia, poor appetite and weight loss (30). 
Suicidal ideation was significantly correlated in all 
concordant twin pairs and was substantially and 
marginally significantly higher in MZ vs DZ twin 
pairs. These results are consistent with previous evi- 
dence from family and adoption studies that suicide 
might itself be influenced by familial factors that are, 
at least in part, probably genetic (31). 
These modest correlations in individual symptoms 
in pairs of concordant twins must be interpreted in 
the context of the reliability of such assessments. We 
are unaware of specific studies of such symptoms 
(although investigators have examined the stability 
of psychotic symptoms in MD (32)). In our sample, 
the mean tetrachoric correlation in symptoms for 
individuals who reported episodes of depression in 
two different years was only r =  0.28. It is therefore 
possible that familial factors account for a substan- 
tial proportion of the variance in the symptoms of 
MD that, in any individual, can be expected to be 
stable over time. 
Birnbaum (33) suggested that clinical character- 
istics of mental disorders could be divided into 
pathogenic and pathoplastic. He defined pathogenic 
clinical features as “ ... those which refer to the ac- 
tual cause of the illness, which endow it with a spe- 
cific characters, its quality of being thus and no 
other”. Pathoplastic features are, by contrast, “those 
which may be said to shape the disorder in that they 
give content, colouring, and contour to individual 
illnesses whose basic form and character have al- 
ready been biologically established”. 
One way in which to view the results of this study 
is as an attempt, in the context of Birnbaum’s the- 
ory, to determine which clinical features of the broad 
syndrome of M D  are pathogenic (influenced by fa- 
milial and especially genetic factors) versus patho- 
plastic (determined by idiosyncratic non-familial fac- 
tors). Our results leave considerable room for the 
operation of both sets of factors. On the one hand, 
the clinical features of MD were not, in our sample, 
randomly distributed in concordant twin pairs, as 
would be expected if they were all pathoplastic aris- 
ing from idiosyncratic personal factors. On the other 
hand, twin resemblance for these clinical features 
was modest at best, even in concordant MZ twins, 
suggesting that individual or pathoplastic features 
are also quite important in the syndrome of MD. 
These results should be interpreted in the context 
of 5 potentially significant methodologic limitations. 
First, because of its low prevalence (34) and low 
reliability in general population samples (35), mania 
was not assessed in our interviews. Therefore, we 
cannot distinguish individuals whose M D  occurred 
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in the setting of unipolar illness from those with 
bipolar illness. From previous prevalence figures, it 
can be estimated that bipolar cases should constitute 
no more than 5-10z of our sample of twins with 
MD. It is possible that some of the observed familial 
aggregation of symptoms of MD result from the ten- 
dency for bipolar illness to itself run in families (1). 
Second, the lifetime prevalence rate for M D  is 
higher in our sample than in several recent epidemi- 
ologic studies using similar diagnostic criteria 
(36, 37). However, these studies used lay-inter- 
viewers and a highly structured psychiatric interview 
(38), a procedure that may underestimate the pop- 
ulation rates of MD (39). Before our probe questions 
for lifetime MD, we included a statement emphasiz- 
ing the need for the respondents to take time to think 
back over their entire life before answering. This may 
have increased our ascertainment rate for prior ep- 
isodes of MD because our ratio of lifetime to one- 
year prevalence in our first interview (3.3: 1) is much 
higher than that obtained in women in the Epidemi- 
ologic Catchment Area study (1.75: 1) (36). In addi- 
tion, the younger age of our twins compared with 
that of most previous population samples may, be- 
cause of a cohort effect (40), also be partly respon- 
sible for the high observed prevalence rates. Finally, 
several recent population-based studies, including at 
least one with very similar methods (41), report life- 
time prevalence rates for MD in women that are as 
high or higher than those reported here (42,43). 
Could being a twin be associated with an increased 
rate of MD? Previous studies have not found differ- 
ent rates of mental disorder in general or depression 
in particular in twins vs singletons (44-46). MZ twins 
are, compared with DZ twins, generally more aware 
of and more affected by their twinness. If twinness 
were associated with MD, one might predict that 
MZ twins should have higher rates of MD than DZ 
twins, a pattern that is not found in the present 
samples (15). 
Third, although we began with a large sample of 
twins, the number of pairs concordant for a lifetime 
history of MD is relatively modest, especially when 
divided by zygosity. Because of this small sample 
and the methodologic issues outlined below, we did 
not attempt formal model fitting, instead limiting 
ourselves to qualitative judgments about the relative 
magnitude of correlations in MZ vs DZ twins. 
Fourth, many tests were performed in these anal- 
yses without strong guiding a priori predictions. Al- 
though the number of significant findings clearly ex- 
ceeded chance expectation, some of the significant 
findings are probably the result of chance fluctua- 
tions. Only replication can definitively resolve which 
of our findings are likely to be true. 
Finally, as we have explored in detail elsewhere 
(47,48), the causes of familial resemblance for dis- 
ease traits can be quite complex and may arise from 
at least 3 different mechanisms. First, a trait can be 
correlated in relatives because it is an index of dis- 
ease liability that is itself familial. For example, if 
severity of impairment reflects the overall liability to 
MD, then pairs of affected relatives will be corre- 
lated for their degree of impairment because they are 
correlated for their overall disease liability. How- 
ever, in this situation, the observed correlation for 
such a trait in relatives will be attenuated due to the 
truncation in the range of disease liability that arises 
from examining only affected individuals. Further- 
more, if the liability is genetically influenced, this 
truncation effect will differ in MZ and DZ twins. 
Although a full model-fitting treatment of this prob- 
lem is available for uncensored data (47), current 
software can not handle the differences in years at 
risk in the present sample. 
Second, disease traits may be correlated in af- 
fected relatives because they are influenced by fa- 
milial factors unrelated to disease liability. For ex- 
ample, certain familial personality characteristics 
may be uncorrelated with the liability to depression 
but, given that an individual is depressed, can influ- 
ence the clinical features of that disorder. 
Third, etiologic heterogeneity could also result in 
correlated disease traits in pairs of affected relatives. 
If typical and atypical MD were different disorders 
but both familial, pairs of relatives would tend to 
have the same form of illness. Therefore, clinical 
features that differed in the two forms of depression 
(such as patterns of eating and sleeping) would be 
correlated in affected relatives. 
Although the problem is a formidable one, we 
hope in the future to develop a more complete model- 
based approach to both detecting the presence and 
determining the possible cause of familial resem- 
blance for symptoms of mental disorders such as 
MD. Because of the modest correlations observed, 
the present sample size of pairs of twins concordant 
for M D  is, however, unlikely to permit a definitive 
resolution of these issues. 
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